The results of the SURPASS-CVOT trial showed that dual GLP-1/GIP agonist Mounjaro (tirzepatide) was as effective as Lilly's ...

Weight-loss patients voice concerns as CVS Caremark drops Zepbound coverage for Wegovy, though exceptions may exist for those ...

Ozempic and Mounjaro are both very popular for weight loss at the minute, but there's one big difference between the two ...

Powerful new medications such as Ozempic and Mounjaro, known as GLP-1 drugs are helping to win the war against obesity in ...

A new study reports that mice shed about 20% of their body weight and saw their breast cancer tumors decrease after getting ...

A variety of GLP-1 drugs that were developed to treat Type 2 diabetes, including Novo Nordisk’s Ozempic, have secured label ...

GLP-1 drugs like semaglutide (Ozempic) and tirzepatide (Mounjaro) may shrink fat, but also crucial muscle mass, with little ...

WEIGHT loss jabs could raise the risk of sudden blindness, a study warns. Injections like Wegovy, Mounjaro and Ozempic are ...

While Ozempic is effective at treating type 2 diabetes and supporting weight loss, it can also come with side effects.

The Danish firm blamed the move to slash its guidance on intense competition from rivals and copycat drugs in the US.